HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DermaQuest Lightener With Hydroquinone Alternative Coming Summer 2008

This article was originally published in The Rose Sheet

Executive Summary

DermaQuest aims to introduce a skin-lightening product containing a safe alternative to hydroquinone in summer 2008, according to founder and CEO Sam Dhatt

You may also be interested in...



SkinMedica, NYU team up against hyperpigmentation

Carlsbad, Calif.-based SkinMedica has exclusive rights to develop and market products based on New York University's technology addressing hyperpigmentation under a deal announced Oct. 26. "Our scientific discovery involves natural products that act by an entirely novel mechanism to modulate skin pigmentation," says Dr. Seth J. Orlow, chair of the Ronald O. Perelman Department of Dermatology at NYU. "The treatment of hyperpigmentation remains a major unmet need," he adds. Mary Fisher, SkinMedica president and CEO, states: "Hyperpigmentation is a very common problem worldwide, with limited treatment options. We look forward to advancing this problem, which has enormous global market potential." SkinMedica sells its products online and to physicians; the firm's offering includes TNS Essential Serum, TNS Recovery Complex and Dermal Repair Cream, priced at $250, $155 and $112, respectively. Competitor DermaQuest markets Skin Lightening Serum and Skin VitaLight, both formulated with melanostatine-5, a peptide it touts as an effective alternative to hydroquinone (1"The Rose Sheet" Dec. 17, 2007)

SkinMedica, NYU team up against hyperpigmentation

Carlsbad, Calif.-based SkinMedica has exclusive rights to develop and market products based on New York University's technology addressing hyperpigmentation under a deal announced Oct. 26. "Our scientific discovery involves natural products that act by an entirely novel mechanism to modulate skin pigmentation," says Dr. Seth J. Orlow, chair of the Ronald O. Perelman Department of Dermatology at NYU. "The treatment of hyperpigmentation remains a major unmet need," he adds. Mary Fisher, SkinMedica president and CEO, states: "Hyperpigmentation is a very common problem worldwide, with limited treatment options. We look forward to advancing this problem, which has enormous global market potential." SkinMedica sells its products online and to physicians; the firm's offering includes TNS Essential Serum, TNS Recovery Complex and Dermal Repair Cream, priced at $250, $155 and $112, respectively. Competitor DermaQuest markets Skin Lightening Serum and Skin VitaLight, both formulated with melanostatine-5, a peptide it touts as an effective alternative to hydroquinone (1"The Rose Sheet" Dec. 17, 2007)

Marketing In Brief

Zirh: Upscale men's skin-care brand Zirh introduces Zirh Platinum, a line that mingles "cosmeceutical science with the best in botanicals," brand says. Eight items in the line utilize peptides with "reparative benefits" and liposomes to "treat moisture loss and aging by restoring skin's barrier function." Natural Moisturizing Factor - a blend of potassium, sodium, magnesium, lactate and urea - helps skin retain moisture and preserves its elasticity, according to the release. Zirh has sourced Kalahari watermelon from the Kalahari Desert in Africa to provide protective and moisturizing benefits. Additional botanicals include extracts of tomato and barley to boost hydration levels and mushroom extract to reduce pore size. Collection initially will be sold exclusively at Barney's New York beginning in April, with an international roll-out to Canada and the U.K. to follow. Items retail for $65 to $145...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015133

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel